• Sunday 08 October 2017
  • 07:30
    EORTC-IDG Breakfast meeting
  • 09:00
    Plenary session 3: MALDI-TOF progress in clinical mycology
  • 09:00
    MALDI identification and more of yeasts

    Oliver Bader, DE
  • 09:00
    MALDI identification and more of moulds

    Maurizio Sanguinetti, IT
  • 10:00
    Coffee break
  • Meet the expert sessions
    • 10:15
      M5 Improvements in the molecular diagnosis of invasive aspergillosis

      Lewis White, UK, FECMM /Willem Melchers, NL
    • 10:15
      M6 Combination treatment of aspergillosis / PRO-CON

      CON: Werner Heinz, DE // PRO: Samir Agrawal, UK
    • 10:15
      M7 Allergic pulmonary fungal diseases and cystic fibrosis: commensals and pathogens

      Predrag Minic, SRB / Malcolm Richardson, UK, FECMM
    • 10:15
      M8 Meet Mrs. Fungus

      Jacques F. Meis, NL, FECMM / Bart Jan Kullberg, NL
  • 11:00
    Poster session
  • 12:00
    Lunch break
  • 12:30
    Sponsored Integrated Symposium 4
    | More info
  • 14:15
    Symposia
  • S13: Diagnosis of invasive mould infection in patients receiving antifungal prophylaxis/treatment
    • 14:15
      Galactomannan

      Martin Hoenigl, AT, FECMM
    • 14:40
      Diagnosis of invasive mould infection in hematology patients: the role of ß-D-glucan

      Daniele Giacobbe, IT
    • 15:05
      Molecular assays

      Dieter Buchheidt, DE, FECMM
    • 15:30
      free communications -- selected abstract
  • S14: Immunology and IFD – where do bench and bedside meet? (or what is clinically relevant?)
    • 14:15
      Experimental animal models of aspergillosis: contribution to the current knowledge of immune-mediated susceptibility

      Milena Kataranovski, SRB
    • 14:40
      Innate immune memory: "training" and beyond

      Jessica Quintin, FR
    • 15:05
      Inborn errors of antifungal immunity

      Anne Puel, FR
    • 15:30
      free communications -- selected abstract
  • S15: New antifungal drugs in the pipeline
    • 14:15
      APX001 (Amplyx)

      Michael Hodges, US
    • 14:27
      CD101 (Cidara)

      Taylor Sandison, US
    • 14:40
      F901318 (F2G)

      John Rex, UK, FECMM
    • 14:52
      AmB (Cochleate)

      Doug Kling, Matinas, US
    • 15:05
      SCY-078 (Scynexis)

      David Angulo, US
    • 15:17
      VT program (Viamet)

      Oren Cohen, US
    • 15:30
      VL-2397 (Vical)
  • S16: FREE COMMUNICATIONS 2
    • 14:15
      Accepted Abstracts
  • 15:45
    Coffee break
  • 16:15
    Symposia
  • S17: Novel biomarkers and diagnostic approaches for fungal infections
    • 16:15
      Monoclonal antibody JF5 for aspergillosis: from BALF to immuno PET/MR

      Chris Thornton, UK
    • 16:40
      TAFC for Aspergillosis: from imaging to Urine analysis

      Hubertus Haas, AT
    • 17:05
      Fungus-reactive T cells for Diagnosing and Monitoring of Invasive Fungal Infections

      Philipp Köhler, DE
    • 17:30
      free communications -- selected abstract
  • S18: Candida auris: An emerging fungal pathogen
    • 16:15
      Pathogenesis of C. auris: role of animal models

      Elizabeth Johnson, UK
    • 16:40
      C. auris: from ear colonisation to fungaemia

      Anuradha Chowdary, IN, FECMM
    • 17:05
      Discovery and control of a protracted C. auris outbreak

      Silke Schelenz, UK
    • 17:30
      free communications -- selected abstract
  • S19: Four mould active azoles in a row, which to go?
    • 16:15
      Posaconazole

      Donald Sheppard, CA, FECMM
    • 16:35
      Isavuconazole

      Maria Vehreschild, DE
    • 16:55
      Voriconazole

      Catherine Cordonnier, FR
    • 17:15
      Itraconazole

      Tom Rogers, IR, FECMM
  • S20: Update on the invasive fungal disease definitions
    • 16:15
       Issues encountered during the consensus

      J. Peter Donnelly (chair, EORTC-IDG)
    • 16:40
      Issues resolved during the consensus

      Pete Pappas, US (chair, MSG-ERC) 
    • 17:05
      Issues remaining – defining possible invasive fungal disease – fungal infection or not

      Johan Maertens, BE (past-chair EORTC IDG), FECMM
  • S21: Progressing ECMM Committees & Working groups
    • 16:15
      ECMM Academy

      Martin Hoenigl, AT, FECMM
    • 16:30
      ECMM Excellence Centers   

      Cornelia Lass-Floerl, AT, FECMM
    • 16:45
      ECMM Directory of Fungal Diagnostic Tests 

      Katrien Lagrou, BE, FECMM
    • 16:55
      ECMM Working groups
    • 16:55
      Fungiscope               

      Oliver A. Cornely, DE, FECMM
    • 17:05
      Azole-resistant A. fumigatus (joint ISHAM WG) 

      Paul Verweij, NL, FECMM
    • 17:15
      Fungal respiratory infections in Cystic fibrosis

      Ana Alastruey-Izquierdo, ES, FECMM
    • 17:25
      Trichosporon Registry                                                 

      Luisa Duran, CL
  • 18:00
    Ben De Pauw Lecture (EORTC)

    Catherine Cordonnier, FR